PharmaCyte Biotech, Inc. (PMCB) (CIK 0001157075) CORRESP
A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.
Key facts
- Accession number
- 0001683168-25-007214
- Form
- CORRESP
- Filer
- PharmaCyte Biotech, Inc. (PMCB) (CIK 0001157075)
- CIK
- 0001157075
- Ticker
- PMCB
- Filed
- 2025-09-24
- SIC industry
- 2836
- HQ
- Las Vegas, NV
Primary source
PDF letter: https://www.sec.gov/Archives/edgar/data/1157075/000168316825007214/filename1.htm
EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗
Other comment-letter activity for this filer